PURPOSE: To report long-term results, prognostic factors and cataract surgery after diabetic vitrectomy. METHODS: Retrospective review of patient files from a large diabetes centre between 1996 and 2010. Surgical history was obtained from the Danish National Patient Register. Follow-up intervals were 3 months and 1, 3, 5 and 10 years after surgery. RESULTS: In total, 167 patients had diabetic vitrectomy indicated for non-clearing vitreous haemorrhage (47%) and tractional retinal detachment (53%). The proportion of patients with visual acuity ≥0.3 increased from 29% before surgery to 60% after 3 months (p < 0.001, chi-square test). Median visual acuity increased from 0.06 before surgery to 0.3 after 3 months (p < 0.001, paired signed-rank test) and 0.4 after 1 year (p = 0.009) before stabilizing. No significant long-term prognostic factors were identified for non-clearing vitreous haemorrhage patients. For tractional retinal detachment patients, use of silicone oil was associated with low vision (visual acuity<0.3) after 3 months and 1, 3 and 5 years (all odds ratios >4 and p-values ≤ 0.03, logistic regression). Of the 134 patients who were phakic after surgery, 43% and 29% were phakic after 5 and 10 years, respectively. Use of silicone oil increased the risk of cataract surgery (p = 0.009, log-rank test). CONCLUSIONS: Most diabetic vitrectomy patients stand to gain visual acuity ≥0.3 after surgery and a stable long-term visual acuity after 1 year. The only consistent long-term predictor of low vision after surgery is use of silicone oil for endotamponade. About 2/3 of phakic patients will subsequently have cataract surgery the first 10 years after diabetic vitrectomy.
PURPOSE: To report long-term results, prognostic factors and cataract surgery after diabetic vitrectomy. METHODS: Retrospective review of patient files from a large diabetes centre between 1996 and 2010. Surgical history was obtained from the Danish National Patient Register. Follow-up intervals were 3 months and 1, 3, 5 and 10 years after surgery. RESULTS: In total, 167 patients had diabetic vitrectomy indicated for non-clearing vitreous haemorrhage (47%) and tractional retinal detachment (53%). The proportion of patients with visual acuity ≥0.3 increased from 29% before surgery to 60% after 3 months (p < 0.001, chi-square test). Median visual acuity increased from 0.06 before surgery to 0.3 after 3 months (p < 0.001, paired signed-rank test) and 0.4 after 1 year (p = 0.009) before stabilizing. No significant long-term prognostic factors were identified for non-clearing vitreous haemorrhagepatients. For tractional retinal detachmentpatients, use of silicone oil was associated with low vision (visual acuity<0.3) after 3 months and 1, 3 and 5 years (all odds ratios >4 and p-values ≤ 0.03, logistic regression). Of the 134 patients who were phakic after surgery, 43% and 29% were phakic after 5 and 10 years, respectively. Use of silicone oil increased the risk of cataract surgery (p = 0.009, log-rank test). CONCLUSIONS: Most diabetic vitrectomy patients stand to gain visual acuity ≥0.3 after surgery and a stable long-term visual acuity after 1 year. The only consistent long-term predictor of low vision after surgery is use of silicone oil for endotamponade. About 2/3 of phakic patients will subsequently have cataract surgery the first 10 years after diabetic vitrectomy.
Authors: Mushfig I Karimov; Elmar M Gasymov; Irada J Aliyeva; Lale A Akhundova; Gunay R Rustambayova; Khalid D Aliyev Journal: Eye (Lond) Date: 2018-05-23 Impact factor: 3.775
Authors: Ahmed Algethami; Mohammed Talea; Wael A Alsakran; Marco Mura; Sulaiman M Alsulaiman Journal: Int Ophthalmol Date: 2020-10-09 Impact factor: 2.031
Authors: Andrew N Antoszyk; Adam R Glassman; Wesley T Beaulieu; Lee M Jampol; Chirag D Jhaveri; Omar S Punjabi; Hani Salehi-Had; John A Wells; Maureen G Maguire; Cynthia R Stockdale; Daniel F Martin; Jennifer K Sun Journal: JAMA Date: 2020-12-15 Impact factor: 56.272
Authors: Jared T Sokol; Sidney A Schechet; Darin T Rosen; Kevin Ferenchak; Sherif Dawood; Dimitra Skondra Journal: PLoS One Date: 2019-08-20 Impact factor: 3.240
Authors: Vivian Schreur; Jody Brouwers; Ramon A C Van Huet; Sandra Smeets; Milan Phan; Carel B Hoyng; Eiko K de Jong; B Jeroen Klevering Journal: Acta Ophthalmol Date: 2020-07-09 Impact factor: 3.761